参考文献/References:
[1] Habeeb NM,Youssef OI,Saab AA,et al.Adiponectin as a marker of complications in type Ⅰ diabetes[J].Indian Pediatr,2012,49(4):277-280.
[2] Hellemons ME, Kerschbaum J, Bakker SJ,et al. Validity of biomarkers predicting onset or progression of nephropathy in patients with type 2 diabetes: a systematic review[J].Diabet Med,2012,29(5):567-577. DOI: 10.1111/j.1464-5491.2011.03437.x.
[3] Kacso IM, Trifa AP, Popp RA,et al. Association of 276G>T adiponectin gene polymorphism to plasma adiponectin and albuminuria in type 2 diabetic patients[J].Int Urol Nephrol,2012,44(6):1771-1777. DOI: 10.1007/s11255-011-0118-4.
[4] Lenghel AR, Kacso IM, Bondor CI,et al. Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients[J].Diabetes Res Clin Pract,2012,95(1):55-61. DOI: 10.1016/j.diabres.2011.08.028.
[5] Jorsal A, Petersen EH, Tarnow L,et al. Urinary adiponectin excretion rises with increasing albuminuria in type 1 diabetes[J].J Diabetes Complications,2013,27(6):604-608. DOI: 10.1016/j.jdiacomp.2013.06.008.
[6] Panduru NM, Saraheimo M, Forsblom C,et al. Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy[J]. Diabetes Care,2015,38(5):883-890. DOI: 10.2337/dc14-2276.
[7] Yu Y, Bao BJ, Fan YP,et al. Changes of adiponectin and its receptors in rats following chronic renal failure[J]. Ren Fail,2014,36(1):92-97. DOI: 10.3109/0886022X.2013.830975.
[8] Jeon WS, Park JW, Lee N,et al. Urinary adiponectin concentration is positively associated with micro- and macro-vascular complications[J].Cardiovasc Diabetol,2013,12:137. DOI: 10.1186/1475-2840-12-137.